Viral vectors have been designed to express genes that replace defective gene expression in patients with congenital disorders including alpha-1-antitrypsin (SERPINA1; A1AT) deficiency, a genetic serpin disorder, or serpinopathy, which causes severe emphysema [13]. This evidence concerns the gene SERPINA1 and hyperinsulinemic hypoglycemia, familial, 4.